(Q60168368)
Statements
A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group (English)
E Bajetta
N Zilembo
S Barni
C Noberasco
L Ferrari
G Schieppati
R Buzzoni
A Jirillo
M Amichetti
M D'Aprile
G Comella
E Bichisao
G F Bolelli
A Attili